{"entity":{"type":"insider","cik":"0001777467","url":"/insider/0001777467","json_url":"/insider/0001777467.json","name":"Leavitt Chase C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2019-08-15","last":"2026-05-11","span_basis":"filed_date"},"name_variants":[{"name":"Leavitt Chase C.","source":"filing","n_filings":5,"first_seen":"2019-08-15","last_seen":"2026-05-11"}],"transactions":[{"id":6043900,"accession":"0001628280-26-033808","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-033808","line_url":"/filing/0001628280-26-033808#line-1","is_derivative":false,"issuer_cik":"0001489993","issuer_name":"Mobia Medical, Inc.","issuer_ticker":"MOBI","issuer_name_source":null,"issuer_url":"/issuer/0001489993","owner_cik":"0001777467","owner_name":"Leavitt Chase C.","owner_display_name":"Leavitt Chase C.","owner_url":"/insider/0001777467","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":45000.0,"total_display":"45,000.00","total_whole":"45,000","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-11","scope":"insider"},{"id":7918426,"accession":"0001209191-23-024264","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-024264","line_url":"/filing/0001209191-23-024264#line-2","is_derivative":false,"issuer_cik":"0001260990","issuer_name":"Oncternal Therapeutics, Inc.","issuer_ticker":"ONCT","issuer_name_source":null,"issuer_url":"/issuer/0001260990","owner_cik":"0001777467","owner_name":"Leavitt Chase C.","owner_display_name":"Leavitt Chase C.","owner_url":"/insider/0001777467","role":"Officer (General Counsel/Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel/Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel/Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":2900.0,"total_display":"2,900.00","total_whole":"2,900","shares_owned_after":106901.0,"shares_owned_after_display":"106,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-13","filed_date":"2023-04-14","scope":"insider"},{"id":7918423,"accession":"0001209191-23-024264","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-024264","line_url":"/filing/0001209191-23-024264#line-1","is_derivative":false,"issuer_cik":"0001260990","issuer_name":"Oncternal Therapeutics, Inc.","issuer_ticker":"ONCT","issuer_name_source":null,"issuer_url":"/issuer/0001260990","owner_cik":"0001777467","owner_name":"Leavitt Chase C.","owner_display_name":"Leavitt Chase C.","owner_url":"/insider/0001777467","role":"Officer (General Counsel/Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel/Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel/Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":4350.0,"total_display":"4,350.00","total_whole":"4,350","shares_owned_after":96901.0,"shares_owned_after_display":"96,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-12","filed_date":"2023-04-14","scope":"insider"},{"id":6918111,"accession":"0001209191-22-005558","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-005558","line_url":"/filing/0001209191-22-005558#line-2","is_derivative":false,"issuer_cik":"0001260990","issuer_name":"Oncternal Therapeutics, Inc.","issuer_ticker":"ONCT","issuer_name_source":null,"issuer_url":"/issuer/0001260990","owner_cik":"0001777467","owner_name":"Leavitt Chase C.","owner_display_name":"Leavitt Chase C.","owner_url":"/insider/0001777467","role":"Officer (General Counsel/Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel/Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel/Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.63,"price_display":"1.63","price_state":"stated","total_value":8150.0,"total_display":"8,150.00","total_whole":"8,150","shares_owned_after":44867.0,"shares_owned_after_display":"44,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-28","filed_date":"2022-01-31","scope":"insider"},{"id":6918104,"accession":"0001209191-22-005558","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-005558","line_url":"/filing/0001209191-22-005558#line-1","is_derivative":false,"issuer_cik":"0001260990","issuer_name":"Oncternal Therapeutics, Inc.","issuer_ticker":"ONCT","issuer_name_source":null,"issuer_url":"/issuer/0001260990","owner_cik":"0001777467","owner_name":"Leavitt Chase C.","owner_display_name":"Leavitt Chase C.","owner_url":"/insider/0001777467","role":"Officer (General Counsel/Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel/Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel/Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8500.0,"shares_display":"8,500","price_per_share":1.78,"price_display":"1.78","price_state":"stated","total_value":15130.0,"total_display":"15,130.00","total_whole":"15,130","shares_owned_after":39867.0,"shares_owned_after_display":"39,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-27","filed_date":"2022-01-31","scope":"insider"},{"id":5199918,"accession":"0001209191-21-040701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-040701","line_url":"/filing/0001209191-21-040701#line-1","is_derivative":false,"issuer_cik":"0001260990","issuer_name":"Oncternal Therapeutics, Inc.","issuer_ticker":"ONCT","issuer_name_source":null,"issuer_url":"/issuer/0001260990","owner_cik":"0001777467","owner_name":"Leavitt Chase C.","owner_display_name":"Leavitt Chase C.","owner_url":"/insider/0001777467","role":"Officer (General Counsel/Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel/Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel/Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":5.45,"price_display":"5.45","price_state":"stated","total_value":8175.0,"total_display":"8,175.00","total_whole":"8,175","shares_owned_after":1500.0,"shares_owned_after_display":"1,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-11","filed_date":"2021-06-15","scope":"insider"},{"id":8619158,"accession":"0001209191-19-046031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-046031","line_url":"/filing/0001209191-19-046031#line-1","is_derivative":false,"issuer_cik":"0000876343","issuer_name":"Lineage Cell Therapeutics, Inc.","issuer_ticker":"LCTX","issuer_name_source":null,"issuer_url":"/issuer/0000876343","owner_cik":"0001777467","owner_name":"Leavitt Chase C.","owner_display_name":"Leavitt Chase C.","owner_url":"/insider/0001777467","role":"Officer (General Counsel/Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel/Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel/Secretary","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.02,"price_display":"1.02","price_state":"stated","total_value":5100.0,"total_display":"5,100.00","total_whole":"5,100","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001489993","name":"Mobia Medical, Inc.","url":"/issuer/0001489993","role":"Officer","n_filings":1,"first_seen":"2026-05-11","last_seen":"2026-05-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001260990","name":"Oncternal Therapeutics, Inc.","url":"/issuer/0001260990","role":"Officer (General Counsel/Secretary)","n_filings":3,"first_seen":"2021-06-15","last_seen":"2023-04-14"},{"type":"issuer","type_label":"ISSUER","cik":"0000876343","name":"Lineage Cell Therapeutics, Inc.","url":"/issuer/0000876343","role":"Officer (General Counsel/Secretary)","n_filings":1,"first_seen":"2019-08-15","last_seen":"2019-08-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001777467","retrieved_at":"2026-08-22T21:48:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}